You are here

Practice Management

 

Adults with hypertension who were at least 75 years old had significantly lower rates of death and fatal and nonfatal major cardiovascular events if they were treated to a systolic blood pressure target of less than 120 mm Hg compared with those treated to a target of less than 140 mm Hg.

 

 

Recent Headlines

Assessing blood pressure over time may help adults understand their risk of stroke and death

A population-based study found that adults whose blood pressure increased rapidly had a high risk of stroke and death. The researchers said that tracking a person’s blood pressure over time may be beneficial in assessing their risk for stroke and mortality.

Older adults with hypertension may benefit from lower systolic blood pressure target

Adults with hypertension who were at least 75 years old had significantly lower rates of death and fatal and nonfatal major cardiovascular events if they were treated to a systolic blood pressure target of less than 120 mm Hg compared with those treated to a target of less than 140 mm Hg.

Medical societies release updated guidelines on two new heart failure medications

Updated guidelines released on May 20 from medical societies in the United States and Europe gave a class I recommendation to sacubitril/valsartan (Entresto), a twice-daily oral heart failure medication that the FDA approved last year.

Aria Health agrees to partner with the Pennsylvania Heart and Vascular Group

Aria Health announced that it had signed an affiliate partnership agreement with the Pennsylvania Heart and Vascular Group. The agreement expands the cardiovascular services and offerings of Aria Health, which is based near Philadelphia and has three community hospitals and a network of outpatient centers.

Missouri cardiologist pleads guilty to making false statements to receive higher reimbursement

Randall E. Meyer, a cardiologist from Jefferson City, Mo., pleaded guilty to making false statements to receive higher reimbursement on healthcare claims.

Study finds cardiologists are unaware of patient nonadherence to medications

More than 60 percent of patients said they rarely or never discussed their adherence to medications with their cardiologists, according to a survey-based study conducted at four cardiology practices in and around Chicago.

Novartis announces clinical trial program for oral heart failure medication

Novartis announced a program that includes more than 40 clinical trials that will examine the safety, efficacy and real world outcomes of patients with heart failure who receive sacubitril/valsartan (Entresto).

USPSTF releases draft research plan on screening for CVD risk and atrial fibrillation with electrocardiography

The U.S. Preventive Services Task Force (USPSTF) released a draft research plan on screening for cardiovascular disease risk and atrial fibrillation with electrocardiography. The plan is open for public comment until June 1 at 8:00 p.m. EST. The USPSTF will read and evaluate the comments and use them to develop a systematic review of the evidence.

Investigational diabetes drug reduces cardiovascular events

Patients with type 2 diabetes who received semaglutide had statistically significant reductions in cardiovascular risk compared with patients who received placebo, according to a phase 3a trial.

Researchers discover gene that may lower non-HDL cholesterol and reduce coronary artery disease risk

Researchers from Iceland discovered a variant of a gene that was associated with reduced levels of non-high density lipoprotein (HDL) cholesterol and a reduction in the risk of coronary artery disease.

Pages